Science & Technology

Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Anticholinergic Drug Induced Dementia

Department of Health and Human Services — National Institutes of Health

Opportunity #: 2R44AG071386-03A1

Award Ceiling

$1.5M

Award Floor

$1.5M

Close Date

Apr 30, 2027

411 days left

Total Funding

$1.5M

Expected Awards

Posted Date

Aug 10, 2025

Cost Sharing Required

Grants.gov ID

sbir-2R44AG071386-03A1

Description

SBIR Phase Phase II award: "Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Anticholinergic Drug Induced Dementia" awarded to HESPEROS, INC in ORLANDO, Florida. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $1,500,000. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.

Eligible Applicants

Small businesses, HUBZone businesses

Apply on Grants.gov

Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.

View on Grants.gov

Disclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.